Results from a phase 2 trial of lixisenatide have been published Date 4 April 2024 Lixisenatide, a diabetes drug being investigated for Parkinson’s, shows potential to slow the progression of movement symptoms.
New research study shows impact of delirium for people with Parkinson’s in hospital Date 21 March 2024 New research study shows impact of delirium for people with Parkinson’s in hospital
Skin biopsy as a potential method towards a test for Parkinson’s Date 21 March 2024 The simple skin test was able to detect a troublesome protein associated with Parkinson's and other similar conditions.
Parkinson’s UK funds nearly £450,000 for research exploring new ways to manage Parkinson’s symptoms Date 19 March 2024 Our latest round of grants fund projects which aim to improve everyday life for people living with Parkinson’s, without the need for extra medications.
Caption Image: Mint Motion for Passionate Productions An update on GDNF trials for Parkinson’s Date 28 February 2024 A further trial of a device-delivered GDNF is not going ahead, but other approaches are showing promise.
Over 10,000 people helping to understand Parkinson’s risk factors Date 14 February 2024 Predict-PD is a study that aims to understand the risk factors of Parkinson’s. More than 10,000 people are now taking part and are representative of the ethnic diversity within the UK population.
New framework aims to use medical tests to improve clinical trials for Parkinson’s Date 23 January 2024 Leading scientists and patient organisations have worked together to develop a framework for using 2 tests to identify Parkinson’s in clinical trials.
Trial looking to delay the onset of Parkinson’s begins Date 9 January 2024 The first participant has been recruited to a pioneering Parkinson’s UK funded clinical trial for people with a sleep behaviour disorder who are at a higher risk of developing Parkinson’s.
New research to explore whether blocking inflammation in the brain may lead to new treatments for Parkinson’s Date 27 December 2023 Studies will investigate the role of inflammation in the brain in Parkinson’s and test whether a new approach to reduce brain inflammation could potentially treat the condition.
Incredible support of Parkinson’s community pushes promising research forward Date 13 December 2023 Earlier this year we launched a campaign to highlight the importance of taking part in Parkinson’s research. Thanks to your support we’ve seen an encouraging boost in recruitment to vital clinical studies.
